VERU INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERU INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $2.57M.
- VERU INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $107.94M, a 8697.25% increase year-over-year.
- VERU INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $12.17M, a 238.14% increase year-over-year.
- VERU INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $1.23M.
- VERU INC. stock issued during period, value, new issues for fiscal 2021 was $107.96M, a 705.69% increase from fiscal 2020.
- VERU INC. stock issued during period, value, new issues for fiscal 2020 was $13.40M, a 272.22% increase from fiscal 2019.
- VERU INC. stock issued during period, value, new issues for fiscal 2019 was $3.60M, a 20.00% increase from fiscal 2018.
- VERU INC. stock issued during period, value, new issues for fiscal 2018 was $3.00M, a 83.32% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-03-31 | $2.57M 10-Q · filed 2024-05-08 | |
| 2021-09-30 | $107.96M 10-K · filed 2022-12-05 | |
| 2021-03-31 | $107.94M 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $13.40M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $12.17M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $1.23M 10-Q · filed 2021-08-12 | |
| 2019-09-30 | $3.60M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $3.60M 10-Q · filed 2020-08-13 | |
| 2018-12-31 | $9.13M 10-Q · filed 2020-08-13 | |
| 2018-09-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $3.00M 10-K · filed 2018-12-13 |
| 2017-12-31 | $347.08K 10-Q · filed 2019-05-15 | |
| 2017-09-30 | $17.98M 10-K · filed 2018-12-13 | |
| 2014-09-30 | $117.60K 10-K · filed 2016-12-12 | |
| 2012-09-30 | $13.00K 10-K · filed 2014-12-02 | |
| 2009-09-30 | $1.86K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |